ClosedPublished 30 Oct 2026
Azenta, Inc. /
SynPlexity Inc.
Azenta adds SynPlexity’s gene library capabilities to GENEWIZ
- Terms
- Not stated
- Stage
- Closed
01 / BuyerAzenta, Inc.
02 / TargetSynPlexity Inc.
What happened
Azenta, Inc. acquired SynPlexity Inc., a synthetic biology company that provides high-throughput gene libraries for biological discovery. The acquisition adds pooled gene assembly technology to Azenta’s GENEWIZ portfolio.
The source
Everything on this page comes from the source below.
01
Source · Source
Azenta adds SynPlexity’s gene library capabilities to GENEWIZ
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly